384 related articles for article (PubMed ID: 15529263)
1. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapy.
Zhang J; Crumpacker CS
J Infect Dis; 2001 Nov; 184(10):1341-4. PubMed ID: 11679927
[TBL] [Abstract][Full Text] [Related]
3. Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts.
Fischer M; Wong JK; Russenberger D; Joos B; Opravil M; Hirschel B; Trkola A; Kuster H; Weber R; Günthard HF;
Antivir Ther; 2002 Jun; 7(2):91-103. PubMed ID: 12212929
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type-1 mRNA splicing pattern in infected persons is determined by the proportion of newly infected cells.
Vesanen M; Markowitz M; Cao Y; Ho DD; Saksela K
Virology; 1997 Sep; 236(1):104-9. PubMed ID: 9299622
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.
Imamichi H; Crandall KA; Natarajan V; Jiang MK; Dewar RL; Berg S; Gaddam A; Bosche M; Metcalf JA; Davey RT; Lane HC
J Infect Dis; 2001 Jan; 183(1):36-50. PubMed ID: 11106537
[TBL] [Abstract][Full Text] [Related]
6. Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivo.
Fischer M; Trkola A; Joos B; Hafner R; Joller H; Muesing MA; Kaufman DR; Berli E; Hirschel B; Weber R; Günthard HF;
Antivir Ther; 2003 Apr; 8(2):97-104. PubMed ID: 12741621
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
[TBL] [Abstract][Full Text] [Related]
8. Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children.
Spiegel HM; DeFalcon E; Ogg GS; Larsson M; Beadle TJ; Tao P; McMichael AJ; Bhardwaj N; O'Callaghan C; Cox WI; Krasinski K; Pollack H; Borkowsky W; Nixon DF
J Infect Dis; 1999 Aug; 180(2):359-68. PubMed ID: 10395850
[TBL] [Abstract][Full Text] [Related]
9. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
10. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines.
Ranki A; Lagerstedt A; Ovod V; Aavik E; Krohn KJ
Arch Virol; 1994; 139(3-4):365-78. PubMed ID: 7832642
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
12. Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes.
Willard-Gallo KE; Furtado M; Burny A; Wolinsky SM
Eur J Immunol; 2001 Apr; 31(4):969-79. PubMed ID: 11298321
[TBL] [Abstract][Full Text] [Related]
13. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
Fang J; Acheampong E; Dave R; Wang F; Mukhtar M; Pomerantz RJ
Virology; 2005 Jun; 336(2):299-307. PubMed ID: 15892970
[TBL] [Abstract][Full Text] [Related]
14. Limitation of Tat-associated transcriptional processivity in HIV-infected PBMC.
Adams M; Wong C; Wang D; Romeo J
Virology; 1999 May; 257(2):397-405. PubMed ID: 10329550
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.
Derdeyn CA; Kilby JM; Miralles GD; Li LF; Sfakianos G; Saag MS; Hockett RD; Bucy RP
J Infect Dis; 1999 Dec; 180(6):1851-62. PubMed ID: 10558941
[TBL] [Abstract][Full Text] [Related]
16. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes.
Tornatore C; Meyers K; Atwood W; Conant K; Major E
J Virol; 1994 Jan; 68(1):93-102. PubMed ID: 8254781
[TBL] [Abstract][Full Text] [Related]
17. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
18. Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretroviral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies.
Lafeuillade A; Poggi C; Hittinger G; Counillon E; Emilie D
J Infect Dis; 2003 Nov; 188(10):1426-32. PubMed ID: 14624367
[TBL] [Abstract][Full Text] [Related]
19. Defective rev response element (RRE) and rev gene in HAART treated AIDS patients with discordance between viral load and CD4+ T-cell counts.
Saurya S; Lichtenstein Z; Karpas A
J Clin Virol; 2005 Aug; 33(4):324-7. PubMed ID: 16005679
[TBL] [Abstract][Full Text] [Related]
20. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
Parisi SG; Boldrin C; Cruciani M; Nicolini G; Cerbaro I; Manfrin V; Dal Bello F; Franchin E; Franzetti M; Rossi MC; Cattelan AM; Romano L; Zazzi M; Andreoni M; Palù G
J Clin Microbiol; 2007 Jun; 45(6):1783-8. PubMed ID: 17442799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
